Skip to content
  • Print

Fellowship in Industry Program in Partnership with Genentech

The Thomas J. Long School of Pharmacy and Health Sciences has partnered with Genentech, Inc. to establish the Fellowship in Industry Program (FIP). Founded in 2017, the program aims to provide exceptional biopharmaceutical industry training for doctor of pharmacy (PharmD) graduates. The goal of the program is to prepare fellows for a career in the pharmaceutical industry by focusing on developing leadership and communication skills. The fellowship also will concentrate on cultivating the fellow's clinical skills while honing their expertise in their area of interest.

Genentech Logo gRED logo


Genentech Fellowship | Clinical Science - Early Clinical Development

Duration: 2 years

gRED's OMNI Early Clinical Development (gRED OMNI ECD) organization is responsible for developing and executing early development clinical strategies in healthy volunteers and patients to provide data for gRED non-oncology new molecular entities with respect to safety, tolerability, efficacy, pharmacokinetics, pharmacodynamics and the utility of biomarkers. This two-year Clinical Science fellowship provides in-depth exposure to Early Clinical Development and understanding the basic principles of Clinical Research. The fellow will function as a Clinical Scientist and may support Medical Directors/senior-level Clinical Scientists on a diverse set of clinical development activities.

Fellows will spend 90% of their time on duties specific to the industry site and 10% of time on professional development activities with the Thomas J Long School of Pharmacy and Health Sciences. All fellows will be eligible for adjunct faculty status. Learn more.   

Fellowship Program Admission 

Eligibility
A candidate must be:

  • A permanent resident or citizen of the United States
  • PharmD from an ACPE accredited college of pharmacy before the start of the fellowship term

The fellowship begins on July 2, 2018 and ends on July 3, 2020.  

Application Process
Participation in the Personnel Placement Service (PPS) at the ASHP Midyear Clinical Meeting is strongly encouraged, but not required.

Before ASHP Midyear Clinical Meeting Interested individuals should request an interview and submit the following through the PPS portal or by e-mail:  

  • Letter of intent
  • Curriculum Vitae (CV)

After ASHP Midyear Clinical Meeting Formal application materials below must be received by December 13th at 11:59pm PST.

  1. Letter of intent
  2. Updated CV
  3. Three (3) letters of recommendation emailed directly to sshah@pacific.edu
  4. Unofficial Pharmacy school or graduate school transcript emailed to sshah@pacific.edu
  5. Official pharmacy school or graduate school transcript(s) mailed to: Dr. Sachin A. Shah, 3601 Pacific Ave, Stockton, CA 95211

"Fellowship opportunities that have a university partner are lacking on the West Coast. This program will offer students more opportunities. The benefit of having a fellowship program at Genentech is that it allows us to develop talent that will contribute to the future of the industry. Next-generation scientists are very important to the future of medicine."
- Jeremy Lim '12, PharmD, associate clinical scientist at Genentech

"The flexibility to customize my training and professional growth is very attractive."
- Kimberly Maiton '17, PharmD, Fellowship in Industry Program health innovation and communication fellow

For more information contact
Sachin A. Shah, PharmD
Fellowship in Industry Program Director
Associate Professor of Pharmacy Practice
sshah@pacific.edu
707.423.3277